Seres Therapeutics, Inc.

MCRB

—

Advanced chart & tools →

Seres Therapeutics, Inc.MCRB

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$0.64

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$789,000

Net income

$5.70M

Net margin

721.9%

Gross margin

—

Dividends & financials

Seres Therapeutics, Inc. (MCRB) reported revenue of $789,000 and net income of $5.70M, or $0.64 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.